CEACAM5 and neoplasm: No significant differences were observed in clinicopathological characteristics as a function of CEA levels; however, CA 125 levels differed significantly as a function of tumor depth (P = 0.020), lymph node metastasis (P = 0.027), and TNM stage (P = 0.007).